Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: Detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161

Archives of Dermatology

Volumn 135, Issue 5, 1999, Pages 546-552

  Nickoloff, Brian J ^a,c   Wrone Smith, Tamara ^a   Bonish, Brian ^a   Porcelli, Steven A ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE TRANSFER; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SCID MOUSE; SKIN GRAFT; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD94; ANTIGENS, SURFACE; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; MICE; MICE, SCID; PSORIASIS; RECEPTORS, IMMUNOLOGIC; SKIN; T-LYMPHOCYTES;

EID: 0032901103     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.5.546     Document Type: Article

References (48)

1. Wrone-Smith T, Nickoloff BJ. Dermal injection of immunocytes induces psoriasis. J Clin Invest. 1996;98:1878-1887.
2. Valdimarsson H, Baker BS, Jonsdotter I, Powles A, Fry L. Psoriasis: a T-cell mediated autoimmune disease induced by streptococcal superantigen? Immunol Today. 1995;16:145-149.
3. Uhrberg M, Valiante NM, Shum BP, et al. Human diversity in killer cell inhibitory receptor genes. Immunity. 1997;7:753-763.
4. Moretta A, Biasson R, Bottino C, et al. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev. 1997;155:105-117.
5. Reyburn H, Mandelboim O, Vales-Gomez M, et al. Human NK cells: their ligands, receptors, and functions. Immunol Rev. 1997;155:119-125.
6. Renard V, Cambriaggi A, Vely F. et al. Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immunol Rev. 1997;155:205-221.
7. Mingari MC, Moretta A, Moretta L. Regulation of KIR expression in human T cell: a safety mechanism that may impair protective T-cell responses. Immunol Today. 1998;19:153-157.
8. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol. 1997;15:535-562.
9. Spada FM, Koezuka Y, Porcelli SA. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med. 1998;188:1529-1534.
10. Mingari MC, Vitale C, Cantoni C, et al. Interleukin-15 induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur J Immunol. 1997; 27:1374-1380.
11. Mingari MC, Ponte M, Bertone S, et al. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen-activated CD8+Tcells. Proc Natl Acad Sci U S A. 1998;95:1172-1177.
12. Houchins JP, Lancier LL, Niemi EC, Phillips JA, Ryan JC. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol. 1997; 158:3603-3609.
13. Houchins JP, Lanier LL, Niemi EC, Phillips JA, Ryan JC. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol. 1997; 158:3603-3609.
14. Cambiaggi A, Orengo AM, Meazza R, et al. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease or granular lymphocytes displays either inhibitory or stimulatory function. Blood. 1996;87: 2369-2375.
15. Exley M, Garcia J, Balk SP, Porcelli S. Requirements for CD1d recognition by human invariant Va24+ CD4-CD8-T cells. J Exp Med. 1997;186:109-120.
16. Fierlbeck G, Russner G, Muller C. Psoriasis induced at the injection site of recombinant gamma interferon. Arch Dermatol. 1990;126:351-355.
17. Takeda K, Dennert G. The development of autoimmunity in C57B1/6 LPR mice correlates with the disappearance of natural killer type-1 positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion and autoimmune symptoms. J Exp Med. 1993;177:155-162.
18. Sumida T, Sakemoto A, Murata H, et al. Selective reduction of T cells bearing invariant Va24aQ antigen receptor in patients with systemic sclerosis. J Exp Med. 1995;182:1163-1168.
19. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell. 1996;85:311-316.
20. Nickoloff BJ. Pathogenesis and immunointervention strategies for psoriasis. Mol Med Today. 1998;4:512-513.
21. Austin LM, Coven TR, Bhardwaj N, Steinman R, Krueger JG. Intraepidermal lymphocytes in psoriatic lesions are activated GMP-17(TIA-1)+ CD8+ CD3+ CTLs as determined by phenotypic analysis. J Cutan Pathol. 1998;25:78-88.
22. Brossay L, Chioda M, Burdin N, et al. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med. 1998;188:1521-1582.
23. Porcelli SA. The CD1 family: a third lineage of antigen-presenting molecules. Adv Immunol. 1995;59:1-98.
24. Valdimarsson H, Baker BS, Jonsdottir I, Fry L. Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today. 1986;7: 257-259.
25. Gardembas-Pain M, Ifrah N, Foussard C, Boasson M, Verrat JL. Psoriasis after allogeneic bone marrow transplantation. Arch Dermatol. 1990;126:1523.
26. Eedy DJ, Burrows D, Bridges JM, Jones FGC. Clearance of severe psoriasis after allogeneic bone marrow transplantation. BMJ. 1990;300:908.
27. Gottlieb SL, Gilleaudeau P, Johnson R, et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte pathogenic basis. Nature Med. 1995;1:442-447.
28. Kalish R, Johnson KL. Enrichment and function of urushiol (poison ivy) specific T lymphocytes in lesions of allergic contact dermatitis to urushiol. J Immunol. 1990;145:3706-3713.
29. Elder JT, Nair RP, Quo SW, Henseler T, Christophers E, Voorhees JJ. The genetics of psoriasis. Arch Dermatol. 1994;130:216-224.
30. Henseler T. The genetics of psoriasis. J Am Acad Dermatol. 1997;37(suppl): 1s-11s.
31. Takada S, Engleman E. Evidence for an association between CD8 molecules and the T cell receptor complex on apoptotic T cells. J Immunol. 1987;139:3231-3235.
32. Chang JCC, Smith LR, Froning KJ, et al. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Proc Natl Acad Sci U S A. 1994;91:9282-9286.
33. Gilhar A, David M, Ullmann Y, Berkutski T, Kalish RS. T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice. J Invest Dermatol. 1997;109:283-288.
34. Nickoloff BJ, Wrone-Smitn T. Superantigens, autoantigens and pathogenic T cells in psoriasis. J Invest Dermatol. 1998;110:459-460.
35. Moretta L, Mingeri MC, Pende D, Bottino C, Biassoni R, Moretta A. The molecular basis of natural killer (NK) cell recognition and function. J Clin Immunol. 1996; 16:243-253.
36. Asahina A, Atazaki S, Nakagawa H, Kuwata S, Tokunaga K, Ishibashi Y. Specific nucleotide sequence of HLA-C is strongly associated with psoriasis vulgaris. J Invest Dermatol. 1991;97:254-258.
37. Bottino C, Sivori S, Vitale M, et al. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol. 1996;26:1816-1829.
38. Nickoloff BJ. The cytokine network in psoriasis. Arch Dermatol. 1991;127:871-884.
39. Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells. Blood. 1995;85:2654-2670.
40. Long EO, Colonna M, Lanier LL. Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. Trends Cell Biol. 1996;17:100.
41. Perez-Villar JJ, Melero J, Rodriguez A, et al. Functional ambivalence of Kp43 (CD94) NK cell-associated surface antigen. J Immunol. 1995;154:5779-5788.
42. Mandelboim O, Reyburn HT, Valas-Gomez M, et al. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med. 1996;184:913-922.
43. Trembath RC, Clough RL, Rosbotham JL, Barker JWN. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by two-stage genome-wide search in psoriasis. Hum Mol Genetics. 1997; 6:813-820.
44. Zhou Y, Chaplin DD. Identification on the HLA class I region of a gene expressed late in differentiation. Proc Natl Acad Sci U S A. 1993;90:9470-9474.
45. Zwirner NW, Fernandez-Vina MA, Stastny P. MICA, a new polymorphic HLA-related antigen is expressed mainly by keratinocytes, endothelial cells, and monocytes: Immunogenetics. 1998;47:139-148.
46. Bahrarn S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A. 1994; 91:6259-6263.
47. Nickoloff BJ, Wrone-Smith T. Animal models of psoriasis. Nature Med. 1997;3: 475-476.
48. Mansbridge JN, Knap AM. Changes in keratinocyte maturation during wound healing. J Invest Dermatol. 1987;89:253-263.